Menu Search
Equities

ZimVie Inc

ZIMV:NSQ

ZimVie Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.74
  • Today's Change0.25 / 1.85%
  • Shares traded2.00
  • 1 Year change+53.69%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year ZimVie Inc was unable to grow net income despite reducing the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percent of sales). Net income shrank 515.65% from a loss of 63.88m to a larger loss of 393.28m despite revenues that were relatively flat.
Gross margin63.18%
Net profit margin-10.58%
Operating margin-6.82%
Return on assets-4.17%
Return on equity-8.55%
Return on investment-4.81%
More ▼

Cash flow in USDView more

In 2023, ZimVie Inc did not generate a significant amount of cash. However, the company earned 37.15m from its operations for a Cash Flow Margin of 8.12%. In addition the company used 15.17m on investing activities and also paid 25.67m in financing cash flows.
Cash flow per share-3.04
Price/Cash flow per share--
Book value per share14.74
Tangible book value per share1.65
More ▼

Balance sheet in USDView more

ZimVie Inc has a Debt to Total Capital ratio of 35.14%, a lower figure than the previous year's 72.59%.
Current ratio1.94
Quick ratio1.38
Total debt/total equity0.5417
Total debt/total capital0.3514
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.